EchoGo® Heart Failure vs Zio ECG Utilization Software (ZEUS) System
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, EchoGo® Heart Failure, is designed for the rapid detection of HFpEF through the analysis of routine echocardiograms, providing quick insights for heart failure diagnosis. In contrast, Tool B, the Zio ECG Utilization Software (ZEUS) System, focuses on analyzing continuous ECG data from wearable monitors to aid in the diagnosis and management of cardiac arrhythmias. While both are AI-powered cardiology tools, they address distinct cardiac conditions and utilize different diagnostic modalities.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure is an AI platform that analyzes routine echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF). The Zio ECG Utilization Software (ZEUS) System, in contrast, analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.
EchoGou00ae Heart Failure analyzes routine echocardiogram video clips, specifically a DICOM file containing a two-dimensional echocardiogram with an apical 4-chamber view. The Zio ECG Utilization Software (ZEUS) System analyzes continuous ECG data collected over up to 14 days from wearable Zio monitors.
EchoGou00ae Heart Failure offers seamless integration with existing workflows and IT stacks, delivering automated structured reports via DICOM workflow to PACS within 20 minutes. The Zio ECG Utilization Software (ZEUS) System provides comprehensive end-of-wear reports for physician review through its ZioSuite web portal and mobile application, and supports HL7-based EHR integration.
EchoGou00ae Heart Failure is clinically validated for HFpEF detection, demonstrating 90% sensitivity and 86% specificity. The Zio ECG Utilization Software (ZEUS) System utilizes proprietary deep-learned algorithms for enhanced diagnostic accuracy in arrhythmia detection and classification, with physicians agreeing with Zio end-of-wear reports 99% of the time.
More Comparisons
Backers
Who funded each tool's parent company.